Synthesis of Benzoquinone Antioxidants and a Bleomycin Disaccharide Library. Mathilakathu Madathil, Manikandadas (Author) / Hecht, Sidney M (Advisor) / Rose, Seth (Committee member) / Woodbury, Neal (Committee member) / Arizona State University (Publisher).; Doctoral Dissertation, ASU Electronic Dissertations and Theses (2013)
The synthesized 5-amino-3-tridecyl-1,4-benzoquinone antioxidants were tested for their ability to protect Friedreich's ataxia (FRDA) lymphocytes from induced oxidative stress. Some of the analogues synthesized conferred cytoprotection in a dose-dependent manner in FRDA lymphocytes at micromolar concentrations.
FULL TEXT PDF
Tuesday, March 26, 2013
Assessment of upper limb function in young Friedreich ataxia patients compared to control subjects using a new three-dimensional kinematic protocol
Assessment of upper limb function in young Friedreich ataxia patients compared to control subjects using a new three-dimensional kinematic protocol.
Nathalie Maurel, Amadou Diop, Arnaud Gouelle, Corinne Alberti, Isabelle Husson; Clinical Biomechanics, Available online 26 March 2013. http://dx.doi.org/10.1016/j.clinbiomech.2013.02.007
Keywords: Friedreich ataxia, Evaluation of upper limb function, Three-dimensional kinematic protocol, Reliability, Measurement errors, Discriminative ability.
Nathalie Maurel, Amadou Diop, Arnaud Gouelle, Corinne Alberti, Isabelle Husson; Clinical Biomechanics, Available online 26 March 2013. http://dx.doi.org/10.1016/j.clinbiomech.2013.02.007
Keywords: Friedreich ataxia, Evaluation of upper limb function, Three-dimensional kinematic protocol, Reliability, Measurement errors, Discriminative ability.
Monday, March 25, 2013
Le phénotype atypique des maladies de Friedreich de début tardif et très tardif
Le phénotype atypique des maladies de Friedreich de début tardif et très tardif. C. Lecocq, K. Nguyen, J.-P. Azulay, A. Durr, M. Pandolfo, C. Tranchant, M. Anheim; Revue Neurologique, Volume 169, Supplement 2, April 2013, Pages A18-A19. http://dx.doi.org/10.1016/j.neurol.2013.01.036
Keywords: Friedreich, Lofa, vlofa, Ataxie cérébelleuse
Keywords: Friedreich, Lofa, vlofa, Ataxie cérébelleuse
Saturday, March 23, 2013
The optic nerve: A “mito-window” on mitochondrial neurodegeneration
The optic nerve: A “mito-window” on mitochondrial neurodegeneration. Alessandra Maresca, Chiara la Morgia, Leonardo Caporali, Maria Lucia Valentino, Valerio Carelli; Molecular and Cellular Neuroscience, Volume 55, July 2013, Pages 62-76. http://dx.doi.org/10.1016/j.mcn.2012.08.004
Keywords: Mitochondrial disease, Optic atrophy, Mitochondrial functions, LHON, DOA, Friedreich ataxia, Retinal ganglion cells.
Keywords: Mitochondrial disease, Optic atrophy, Mitochondrial functions, LHON, DOA, Friedreich ataxia, Retinal ganglion cells.
Friday, March 22, 2013
A New Assessment Tool for Ataxia Syndromes: The "STAND" (Scale To Assess Ataxia and Neurologic Dysfunction)
A New Assessment Tool for Ataxia Syndromes: The "STAND" (Scale To Assess Ataxia and Neurologic Dysfunction). Theresa Zesiewicz, Jessica Shaw, Israt Jahan, Kelly Sullivan, Kevin Allison, Joseph Staffetti, Patricia Greenstein, Clifton Gooch, Tuan Vu; AAN poster 2013
Objective: To evaluate a new ataxia rating scale, the STAND (Scale To assess Ataxia and Neurologic Dysfunction).
Objective: To evaluate a new ataxia rating scale, the STAND (Scale To assess Ataxia and Neurologic Dysfunction).
Wednesday, March 20, 2013
Families Push for New Ways to Research Rare Diseases
Families Push for New Ways to Research Rare Diseases . A version of this article appeared February 19, 2013, on page D1 in the U.S. edition of The Wall Street Journal, with the headline: Families Push For New Ways To Research Rare Diseases.
Parents with children who have rare and debilitating diseases are pushing to change how researchers develop medicines to treat the conditions.
The idea of sharing medical data from patients with rare diseases is gaining backing from public-health officials at the National Institutes of Health and the Food and Drug Administration
Companies and academic researchers, though, are often reluctant to cede control of what they consider proprietary information.
Parents with children who have rare and debilitating diseases are pushing to change how researchers develop medicines to treat the conditions.
The idea of sharing medical data from patients with rare diseases is gaining backing from public-health officials at the National Institutes of Health and the Food and Drug Administration
Companies and academic researchers, though, are often reluctant to cede control of what they consider proprietary information.
Tuesday, March 19, 2013
Epidemiology of Hereditary Ataxias in Spain: Hospital Discharge Registry and Population-Based Mortality Study
Epidemiology of Hereditary Ataxias in Spain: Hospital Discharge Registry and Population-Based Mortality Study. Alonso V., Villaverde-Hueso A., Hens M.J., Morales-Piga A., Abaitua I., Posada de la Paz M.; Neuroepidemiology 2013;41:13-19 (DOI:10.1159/000346275).
Keywords: Hereditary ataxias (HA), genetically heterogeneous rare diseases, morbimortality of HA, national death index (1981-2008), Friedreich's ataxia (45.4%), non-Friedreich group(54.6%).
Keywords: Hereditary ataxias (HA), genetically heterogeneous rare diseases, morbimortality of HA, national death index (1981-2008), Friedreich's ataxia (45.4%), non-Friedreich group(54.6%).
Discovery of a Novel Small Molecule Inhibitor Targeting the Frataxin/Ubiquitin Interaction via Structure-Based Virtual Screening and
Discovery of a Novel Small Molecule Inhibitor Targeting the Frataxin/Ubiquitin Interaction via Structure-Based Virtual Screening and. Antonio Lavecchia, Carmen Di Giovanni, Carmen Cerchia, Annapina Russo, Giulia Russo, Ettore Novellino; J. Med. Chem., Just Accepted Manuscript. DOI: 10.1021/jm3017199
Keywords: Friedreich ataxia (FRDA), frataxin, ubiquitin–proteasomal pathway, residue K147, potential ubiquitin-binding domain.
Keywords: Friedreich ataxia (FRDA), frataxin, ubiquitin–proteasomal pathway, residue K147, potential ubiquitin-binding domain.
Sunday, March 17, 2013
Motor manifestations and basal ganglia output activity: The paradox continues
Motor manifestations and basal ganglia output activity: The paradox continues. Jose A. Obeso, J. Guridi, A. Nambu and A.R. Crossman. Movement Disorders. Article first published online: 14 MAR 2013 | DOI: 10.1002/mds.25358
KeR-EGI, a new index of gait quantification based on electromyography
KeR-EGI, a new index of gait quantification based on electromyography. Kristell Bervet, Manon Bessette, Lucille Godet, Armel Crétual; Journal of Electromyography and Kinesiology, Available online 16 March 2013. http://dx.doi.org/10.1016/j.jelekin.2013.02.006
Keywords: Gait analysis in adults, EMG-based gait quantification, Gait Deviation Index, Edinburgh Visual Gait Score
Keywords: Gait analysis in adults, EMG-based gait quantification, Gait Deviation Index, Edinburgh Visual Gait Score
Subscribe to:
Posts (Atom)
